A. Cerar

535 total citations
35 papers, 354 citations indexed

About

A. Cerar is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, A. Cerar has authored 35 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 13 papers in Cardiology and Cardiovascular Medicine and 7 papers in Molecular Biology. Recurrent topics in A. Cerar's work include Tissue Engineering and Regenerative Medicine (7 papers), Cardiac Structural Anomalies and Repair (5 papers) and Mesenchymal stem cell research (5 papers). A. Cerar is often cited by papers focused on Tissue Engineering and Regenerative Medicine (7 papers), Cardiac Structural Anomalies and Repair (5 papers) and Mesenchymal stem cell research (5 papers). A. Cerar collaborates with scholars based in Slovenia, United States and Czechia. A. Cerar's co-authors include Martina Perše, Mario Poljak, Gregor Poglajen, Željka Večerić‐Haler, Janina Orłowska, Bojan Vrtovec, Mark J. Arends, I C Talbot, Patricia Gorman and A M Hanby and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Circulation Research.

In The Last Decade

A. Cerar

34 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Cerar Slovenia 12 132 115 105 88 54 35 354
RM Schmid Germany 9 119 0.9× 136 1.2× 114 1.1× 24 0.3× 27 0.5× 17 358
Alejandra Avagnina Argentina 10 79 0.6× 73 0.6× 76 0.7× 61 0.7× 23 0.4× 40 368
Hoon Ryu South Korea 12 139 1.1× 80 0.7× 80 0.8× 44 0.5× 15 0.3× 25 385
Limin Xia China 9 187 1.4× 76 0.7× 57 0.5× 19 0.2× 84 1.6× 21 346
Qin Jiang China 12 117 0.9× 57 0.5× 24 0.2× 52 0.6× 111 2.1× 30 332
Sonia Nogueras Spain 10 122 0.9× 89 0.8× 37 0.4× 18 0.2× 44 0.8× 17 350
F. Luccioli Italy 11 136 1.0× 86 0.7× 40 0.4× 65 0.7× 32 0.6× 19 441
J.J. Dubost France 8 105 0.8× 53 0.5× 56 0.5× 24 0.3× 23 0.4× 30 366
Toshiyuki Okuma Japan 7 99 0.8× 159 1.4× 96 0.9× 50 0.6× 161 3.0× 16 478
Daniel Ching Australia 11 101 0.8× 144 1.3× 62 0.6× 22 0.3× 37 0.7× 28 429

Countries citing papers authored by A. Cerar

Since Specialization
Citations

This map shows the geographic impact of A. Cerar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Cerar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Cerar more than expected).

Fields of papers citing papers by A. Cerar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Cerar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Cerar. The network helps show where A. Cerar may publish in the future.

Co-authorship network of co-authors of A. Cerar

This figure shows the co-authorship network connecting the top 25 collaborators of A. Cerar. A scholar is included among the top collaborators of A. Cerar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Cerar. A. Cerar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qayyum, Abbas Ali, Morten Juhl, Gregor Poglajen, et al.. (2024). Mesenchymal Stromal Cells to Treat Patients with Non-Ischaemic Heart Failure: Results from SCIENCE II Pilot Study. ESC Heart Failure. 11(6). 3882–3891. 4 indexed citations
2.
Poglajen, Gregor, et al.. (2023). Abstract 15501: Effects of Vericiguat on Right Ventricular Function in Chronic Heart Failure Patients. Circulation. 148(Suppl_1). 1 indexed citations
3.
Vrtovec, Bojan, Gregor Poglajen, A. Cerar, et al.. (2022). A pilot clinical trial of cell therapy in heart failure with preserved ejection fraction. European Journal of Heart Failure. 24(8). 1441–1449. 4 indexed citations
4.
Poglajen, Gregor, et al.. (2020). QuantiFERON-CMV guided virostatic prophylaxis after heart transplantation. The Journal of Heart and Lung Transplantation. 39(3). 278–281. 11 indexed citations
5.
Poglajen, Gregor, et al.. (2020). Larger End-Diastolic Volume Associates With Response to Cell Therapy in Patients With Nonischemic Dilated Cardiomyopathy. Mayo Clinic Proceedings. 95(10). 2125–2133. 8 indexed citations
6.
Cerar, A., et al.. (2020). Impairment of Myocardial Perfusion Correlates with Heart Failure Severity in Patients With Non-Compaction Cardiomyopathy. ESC Heart Failure. 7(3). 1161–1167. 4 indexed citations
7.
Poglajen, Gregor, et al.. (2020). Stem Cell Therapy for Chronic and Advanced Heart Failure. Current Heart Failure Reports. 17(5). 261–270. 5 indexed citations
8.
9.
Poglajen, Gregor, et al.. (2019). Quantiferon-CMV Guided Virostatic Prophylaxis after Heart Transplantation. The Journal of Heart and Lung Transplantation. 38(4). S119–S119. 2 indexed citations
10.
Vrtovec, Bojan, Martina Jaklič, Gregor Poglajen, et al.. (2017). Abstract 15952: A Pilot Trial of CD34+ Cell Therapy in Heart Failure With Preserved Ejection Fraction. Circulation. 2 indexed citations
11.
Cerar, A., et al.. (2016). LVAD as a Bridge to Heart Transplantation in a Patient with Left Ventricular Noncompaction Cardiomyopathy and Advanced Heart Failure. The Heart Surgery Forum. 19(3). 128–128. 5 indexed citations
12.
Cerar, A., et al.. (2014). Long-term follow up after transcatheter closure of atrial septal defect and patent foramen ovale in adults. SHILAP Revista de lepidopterología.
13.
Perše, Martina & A. Cerar. (2013). Animal models of human pathology - our experience.. Slovenian Veterinary Research. 50(3). 127–138. 1 indexed citations
14.
Perše, Martina, Rade Injac, Borut Štrukelj, & A. Cerar. (2012). High Fat Mixed Lipid Diet Modifies Protective Effects of Exercise on 1,2 Dimethylhydrazine Induced Colon Cancer in Rats. Technology in Cancer Research & Treatment. 11(3). 289–299. 11 indexed citations
15.
Perše, Martina, A. Cerar, Rade Injac, & Borut Štrukelj. (2008). N-methylnitrosourea Induced Breast Cancer in Rat, the Histopathology of the Resulting Tumours and its Drawbacks as a Model. Pathology & Oncology Research. 15(1). 115–121. 29 indexed citations
16.
Cerar, A., et al.. (2007). Dimethylhydrazine model is not appropriate for evaluating effect of ethanol on colorectal cancer. Revista Española de Enfermedades Digestivas. 99(8). 463–6. 4 indexed citations
17.
Sawyer, Elinor J., A. Cerar, A M Hanby, et al.. (2002). Molecular characteristics of serrated adenomas of the colorectum. Gut. 51(2). 200–206. 75 indexed citations
18.
Vodovnik, Aleksandar & A. Cerar. (2000). Synchronous herpes simplex virus and cytomegalovirus esophagitis. Zeitschrift für Gastroenterologie. 38(6). 491–494. 11 indexed citations
19.
Poljak, Mario, A. Cerar, & Janina Orłowska. (1996). p53 Protein Expression in Esophageal Squamous Cell Papillomas: A Study of 36 Lesions. Scandinavian Journal of Gastroenterology. 31(1). 10–13. 13 indexed citations
20.
Orłowska, Janina, et al.. (1995). Human papillomavirus infection in esophageal squamous cell papillomas: a study of 29 lesions.. PubMed. 15(3). 965–9. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026